Cortland Associates Inc. MO Sells 48,495 Shares of The Cigna Group (NYSE:CI)

Cortland Associates Inc. MO cut its position in The Cigna Group (NYSE:CI - Free Report) by 27.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 126,944 shares of the health services provider's stock after selling 48,495 shares during the quarter. The Cigna Group comprises 4.0% of Cortland Associates Inc. MO's holdings, making the stock its 12th biggest position. Cortland Associates Inc. MO's holdings in The Cigna Group were worth $35,054,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Foster & Motley Inc. lifted its stake in The Cigna Group by 8.5% during the fourth quarter. Foster & Motley Inc. now owns 6,695 shares of the health services provider's stock valued at $1,849,000 after purchasing an additional 522 shares during the last quarter. Swedbank AB lifted its position in shares of The Cigna Group by 55.1% in the 4th quarter. Swedbank AB now owns 884,406 shares of the health services provider's stock valued at $244,220,000 after acquiring an additional 314,123 shares in the last quarter. Strategic Blueprint LLC boosted its stake in The Cigna Group by 9.8% in the 4th quarter. Strategic Blueprint LLC now owns 805 shares of the health services provider's stock worth $222,000 after purchasing an additional 72 shares during the period. Forsta AP Fonden grew its position in The Cigna Group by 8.8% during the 4th quarter. Forsta AP Fonden now owns 97,500 shares of the health services provider's stock worth $26,924,000 after purchasing an additional 7,900 shares in the last quarter. Finally, Foster Victor Wealth Advisors LLC raised its stake in The Cigna Group by 20.5% during the 4th quarter. Foster Victor Wealth Advisors LLC now owns 55,109 shares of the health services provider's stock valued at $15,650,000 after purchasing an additional 9,364 shares during the period. 86.99% of the stock is owned by institutional investors.

The Cigna Group Trading Down 7.5 %

NYSE:CI traded down $22.87 during mid-day trading on Thursday, hitting $280.44. The company had a trading volume of 4,126,473 shares, compared to its average volume of 1,701,391. The firm has a market cap of $78.00 billion, a P/E ratio of 26.44, a P/E/G ratio of 0.78 and a beta of 0.54. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83. The business's fifty day moving average is $296.05 and its two-hundred day moving average is $324.99. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72.

The Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. During the same quarter in the prior year, the business posted $6.79 EPS. As a group, research analysts expect that The Cigna Group will post 28.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

CI has been the topic of several recent analyst reports. Truist Financial dropped their price target on The Cigna Group from $420.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. StockNews.com cut The Cigna Group from a "strong-buy" rating to a "buy" rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft dropped their price target on The Cigna Group from $398.00 to $394.00 and set a "buy" rating on the stock in a research report on Monday, November 4th. Piper Sandler reaffirmed an "overweight" rating and set a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. Finally, Stephens reiterated an "overweight" rating and set a $410.00 price target on shares of The Cigna Group in a research note on Friday, November 1st. One equities research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $395.93.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.